FIOR Bioscience
FIOR Bioscience is a leader in regenerative medicine, focusing on the development and manufacturing of safe, effective postnatal stem cell biological medicines. With over 15 years of experience, they emphasize innovation, safety, and integrity in their products, which are sourced from donated postnatal tissues and are intended for homologous use by licensed medical professionals.
Industries
Nr. of Employees
medium (51-250)
FIOR Bioscience
Sandy, Utah, United States, North America
Products
StemVive
Concentrated cryopreserved flowable stem cell product formulated with growth factors for clinical use.
StemMaxx
Cryopreserved flowable cellular biologic containing extracellular matrix components.
StemTru
Cryopreserved flowable umbilical cord blood–derived biologic with anti-inflammatory properties.
StemCellect
Cryopreserved Wharton's Jelly–derived flowable product biologically rich in mesenchymal stem cells.
CellLift
Cryopreserved flowable cellular biologic with additional extracellular matrix intended for dermal use.
BioSpackle
Freeze-dried topical wound care biologic intended for topical application.
StemVive
Concentrated cryopreserved flowable stem cell product formulated with growth factors for clinical use.
StemMaxx
Cryopreserved flowable cellular biologic containing extracellular matrix components.
StemTru
Cryopreserved flowable umbilical cord blood–derived biologic with anti-inflammatory properties.
StemCellect
Cryopreserved Wharton's Jelly–derived flowable product biologically rich in mesenchymal stem cells.
CellLift
Cryopreserved flowable cellular biologic with additional extracellular matrix intended for dermal use.
BioSpackle
Freeze-dried topical wound care biologic intended for topical application.
Services
Postnatal tissue processing and supply
Processing of postnatal tissues into cryopreserved or formulated cellular biologics and distribution of those products to licensed medical professionals.
Donor screening and tissue recovery
Donor eligibility screening (including multi-generation medical history and infectious disease screening), in-hospital tissue collection by recovery specialists, and chain-of-custody documentation.
Regulatory, quality and compliance oversight
Quality program and regulatory affairs oversight including documentation, audits, and regulatory interactions focused on HCT/P minimal manipulation and homologous use compliance.
Postnatal tissue processing and supply
Processing of postnatal tissues into cryopreserved or formulated cellular biologics and distribution of those products to licensed medical professionals.
Donor screening and tissue recovery
Donor eligibility screening (including multi-generation medical history and infectious disease screening), in-hospital tissue collection by recovery specialists, and chain-of-custody documentation.
Regulatory, quality and compliance oversight
Quality program and regulatory affairs oversight including documentation, audits, and regulatory interactions focused on HCT/P minimal manipulation and homologous use compliance.
Expertise Areas
- Regenerative medicine and cellular therapies
- Mesenchymal stem cell processing and characterization
- Postnatal tissue procurement and donor screening
- Cryopreservation and biobanking
Key Technologies
- Cryopreservation
- Lyophilization (freeze-drying)
- Stem cell isolation methods
- In vitro MSC expansion and marker-based characterization